Evidence-based clinical reference for nurses in the Gulf Cooperation Council
Neurology
Parkinson's Disease — Overview & Pathophysiology
Understanding the disease basis underpins all nursing assessments and interventions
🧠Pathophysiology
Progressive neurodegenerative disorder of the basal ganglia
Loss of dopaminergic neurons in the substantia nigra pars compacta
Symptoms emerge when ~60–80% of dopaminergic neurons are lost
Lewy bodies — intracytoplasmic inclusions of alpha-synuclein protein — hallmark finding
Dopamine deficiency disrupts the striato-thalamo-cortical motor loop → motor symptoms
Non-dopaminergic pathways also affected (serotonin, noradrenaline, acetylcholine)
Braak staging theory: pathology spreads caudally → rostrally over years
⚠️TRAP — Cardinal Motor Features
T — Tremor at Rest
Pill-rolling hand tremor; 4–6 Hz; worsens with stress; suppressed by voluntary movement; often asymmetric onset
R — Rigidity
Cogwheel (ratchety, tremor superimposed) or leadpipe (uniform resistance) — assess at wrist and elbow
A — Akinesia / Bradykinesia
Slowness & reduced amplitude of movement — micrographia, hypomimia (mask face), soft voice (hypophonia), reduced arm swing
P — Postural Instability
Later sign; impaired righting reflexes; positive pull test; festination, freezing of gait; major fall risk
Non-Motor Features
🫀Autonomic Dysfunction
Orthostatic hypotension — fall risk; BP drop ≥20 mmHg systolic on standing
Constipation — often precedes motor symptoms by years
Urinary urgency / nocturia / incomplete emptying
Excessive sweating, seborrhea
Sexual dysfunction
Sialorrhoea (pooling, not excess production)
🧩Neuropsychiatric Features
Depression — ~40% of patients; often under-recognised
Dementia — up to 80% over disease course (Parkinson's disease dementia)
Anxiety, apathy, fatigue
Psychosis — hallucinations (visual most common); often medication-related
Impulse control disorders (medication side effect)
Cognitive slowing, executive dysfunction
😴Sleep Disorders
REM Sleep Behaviour Disorder (RBD) — may predate diagnosis by 10+ years; acting out dreams; risk of injury
Insomnia, fragmented sleep
Restless legs syndrome
Excessive daytime sleepiness
Sleep apnoea
Anosmia — loss of smell; prodromal marker of PD
Hoehn & Yahr Staging
Stage
Description
Functional Impact
Nursing Considerations
I
Unilateral disease only
Minimal; independent ADLs
Education, medication adherence, safety awareness
II
Bilateral, no balance impairment
Mild gait/posture changes
Exercise promotion, fall prevention education
III
Bilateral + mild postural instability
Slowed; independent
Falls risk assessment, home hazard review, physiotherapy referral
IV
Severe; limited independence
Needs assistance; can stand unaided
Carer support, OT assessment, medication optimisation
V
Wheelchair/bedridden
Fully dependent
Pressure care, nutrition support, advance care planning
GCC Epidemiology
🌍Parkinson's in the Gulf Region
Prevalence rising with the ageing GCC population — UAE, Saudi Arabia, Qatar have rapidly growing older demographics
Parkinson's likely under-diagnosed — symptoms attributed to normal ageing or other conditions
Later presentation is common — patients may present at Hoehn & Yahr III–IV at diagnosis
Movement disorder neurology services concentrated in major tertiary centres
Dedicated Parkinson's nurse specialists rare across the region
Significant role for general nurses in recognising and managing Parkinson's in all care settings
Medications — Critical Timing & Safety
Medication timing is the single most important nursing intervention in Parkinson's care
CRITICAL NURSING PRINCIPLE — TIMING IS EVERYTHING
Parkinson's medications — especially levodopa — MUST be given at the patient's prescribed times. A delay of even 30–60 minutes can cause severe motor deterioration, immobility, and distress. Never omit or delay without specialist review.
First-Line Therapy — Levodopa
💊Levodopa / Carbidopa (Sinemet, Madopar)
Levodopa is the most effective dopamine replacement. Carbidopa (or benserazide in Madopar) inhibits peripheral decarboxylase — reduces nausea and increases CNS availability.
Available as immediate release (IR) and controlled release (CR)
IR: shorter acting, faster onset — useful for early-morning doses
CR: slower onset — not suitable as first morning dose alone
Give on an empty stomach or light snack — high-protein meals significantly reduce absorption
Ideal: 30–60 minutes before meals (see Nutrition tab)
Motor Fluctuations
Wearing Off
End-of-dose deterioration before next dose is due; predictable; manage by shortening dosing interval or adding COMT inhibitor
On-Off Phenomenon
Unpredictable swings between mobility (ON) and immobility (OFF); more common in advanced disease; dyskinesias occur at peak dose
Dyskinesias
Involuntary writhing movements at peak levodopa levels; may require dose reduction, amantadine, or surgical review
Other Parkinson's Medications
🟢Dopamine Agonists
Pramipexole, Ropinirole (oral)
Non-ergot agonists; first-line especially in younger patients; longer acting than levodopa
Rotigotine Patch (Neupro)
Transdermal — useful when oral route unavailable (NBM, dysphagia); rotate patch site daily; apply to dry, hairless skin
Impulse Control Disorders (ICDs)
All dopamine agonists carry risk: compulsive gambling, hypersexuality, binge eating, excessive shopping. Screen at every review. If suspected, urgent specialist referral — do NOT abruptly stop medication.
🔬Adjunct Therapies
MAO-B Inhibitors
Rasagiline, Selegiline — inhibit dopamine breakdown; mild-moderate benefit; selegiline metabolised to amphetamine (insomnia); avoid with SSRIs/SNRIs (serotonin syndrome risk)
COMT Inhibitors
Entacapone (Comtess) — always given with levodopa; prolongs levodopa effect; reduces wearing off; orange discolouration of urine (inform patient)
Amantadine
Anti-glutamatergic; reduces dyskinesias; also used for freezing of gait; side effects: livedo reticularis, ankle oedema, confusion
Contraindicated & High-Risk Medications
🚫NEVER Give Without Specialist Review — Drug-Induced Parkinsonism
These drugs block dopamine receptors and can precipitate or severely worsen Parkinsonism. They must NEVER be prescribed to Parkinson's patients without movement disorder specialist review.
CONTRAINDICATED Anti-emetics
Metoclopramide (Maxolon) — dopamine antagonist; frequently prescribed for nausea — NEVER use in PD
Prochlorperazine (Stemetil) — commonly used for vertigo/nausea — CONTRAINDICATED
All typical antipsychotics — chlorpromazine, flupentixol, zuclopenthixol
Most atypicals — risperidone, olanzapine — avoid or use with extreme caution
SAFER options for PD psychosis: Quetiapine, Clozapine (specialist-only)
Clinical Alert
If a Parkinson's patient is admitted and new medications are prescribed by non-specialist teams (A&E, surgery, medical), the nursing team must check every new drug against this list and query with pharmacy/neurology before administration.
Hospital Management — The Danger Zone
Hospitalisation is a period of extreme vulnerability for Parkinson's patients
Parkinson's UK Evidence
1 in 10 Parkinson's patients experience a serious adverse event during hospitalisation due to medication errors — missed doses, wrong timing, contraindicated drugs, or inability to swallow medications. Nurses are the last line of defence.
🏥Top Hospital Risks
Medications prescribed at wrong times by non-specialist ward staff
Doses omitted due to NBM status or swallowing difficulties
Medication delays due to ward supply or pharmacy issues
Rapid deterioration — patient becomes bed-bound within hours of missed doses
Aspiration pneumonia from unmanaged dysphagia
Falls due to postural hypotension + unfamiliar environment
⏰Medication Timing on Admission
On admission, immediately document patient's home medication schedule (exact times)
Do NOT change times to fit standard ward drug rounds
Prescribe on drug chart with specific times — not "TDS" or "with meals"
Allow self-administration where assessed safe and appropriate
Inform ALL staff including night shifts of Parkinson's medication priority
Contact family/carer to confirm home medication regime
Attach a "Parkinson's Medication Alert" sticker to bed/notes
Nil by Mouth (NBM) Management
🚨When the Patient Cannot Swallow Oral Medications
Never simply omit Parkinson's medications for an NBM patient — seek urgent specialist advice within 1 hour of NBM instruction.
Contact neurology / Parkinson's team immediately when NBM is planned or unplanned
Discuss alternatives with pharmacy and prescribing team
Document time of last levodopa dose and expected "off" time
NBM Alternatives
Rotigotine Patch (Neupro)
Can be continued during NBM; provides continuous dopaminergic coverage; does not replace levodopa fully but maintains background
Nasogastric (NG) Tube
Crush immediate-release levodopa tablets and administer via NG; do NOT crush controlled-release formulations
Apomorphine SC Infusion
Subcutaneous dopamine agonist; rescue therapy or continuous infusion; requires specialist setup; highly effective rescue in OFF states
Falls Prevention
⚠️Falls — Extremely High Risk in Hospital
Parkinson's-Specific Fall Mechanisms
Freezing of gait (FOG) — sudden inability to initiate walking; especially at doorways, turns, narrow spaces
Festination — accelerating shuffling steps; patient unable to stop
Postural instability — impaired righting reflexes
Orthostatic hypotension — dizziness on standing
Reduced arm swing → cannot break a fall
Nocturia → falls at night trying to reach bathroom
Hospital Interventions
Falls risk assessment (FES / Morse) on admission — document as HIGH RISK
Bed in low position; non-slip footwear
Call bell within reach; educate patient on asking for help
Physiotherapy referral within 24 hours of admission
Cot sides — assess carefully; may increase risk if patient tries to climb over
Floor-level bed mats; falls alarm sensor if available
Visual cues on floor for FOG management (stripes to step over)
Ensure orthostatic BP measured and documented
Hospital Admission Checklist
✅Parkinson's Admission Actions
Dysphagia & Nutrition in Parkinson's
Swallowing difficulties are present in up to 80% of patients and are a major cause of morbidity
Refer to SALT on Admission
All Parkinson's patients admitted to hospital should have a swallowing screen. Pharyngeal dysfunction in Parkinson's is often clinically silent — patients do not always cough despite aspirating (silent aspiration).
🗣️Swallowing in Parkinson's
Bradykinesia affects all phases of swallowing — oral, pharyngeal, oesophageal
Drooling (sialorrhoea) — not excess saliva; reduced swallowing frequency; managed with anticholinergics or glycopyrronium spray
Silent aspiration — no cough reflex triggered; high pneumonia risk
Thin liquids most commonly aspirated — thickening agents required
Fatigue during meals — small, frequent meals recommended
Upright positioning during and 30 min after meals mandatory
Double swallow technique helpful — ask patient to swallow twice per mouthful
🥗IDDSI Framework — Texture Modification
IDDSI (International Dysphagia Diet Standardisation Initiative) used across GCC
Levels 0–4 for drinks (thin → extremely thick)
Levels 3–7 for foods (liquidised → regular)
Implement texture/thickness as per SALT recommendation — do not assume
Document texture level on drug chart, nursing care plan, and meal ordering
Reassess regularly — swallowing function changes with disease state and medications
Oral hygiene is critical — aspirated oral bacteria causes pneumonia
Levodopa & Protein Interaction — Clinical Importance
🔬Protein Redistribution Diet
Why Protein Matters
Dietary amino acids compete with levodopa at the blood-brain barrier transport system. High protein meals significantly reduce levodopa absorption and CNS delivery — worsening motor control.
Give levodopa 30–60 minutes before meals where possible
If taken with food: use a low-protein snack (crackers, fruit) rather than a protein-rich meal
Protein redistribution strategy: keep protein intake low during daytime (when mobility needed); have main protein intake in the evening
Practical Nursing Points
Timing Documentation
Ensure medication administration times on drug chart allow 30-60 min gap before meal tray arrives. Coordinate with catering team.
Daytime Low-Protein
Bread, rice, pasta, vegetables, fruit at breakfast and lunch. Reserve meat, fish, cheese, eggs, beans for evening meal.
Dietitian Referral
For formal protein redistribution counselling, weight loss, or Duodopa patients — involve dietitian early
Constipation Management
🔄Constipation — A Core Feature of Parkinson's
Constipation often predates motor symptoms by 10+ years — an early autonomic sign
Caused by reduced GI motility (autonomic neuropathy + bradykinesia of gut wall)
Severe constipation impairs levodopa absorption — worsening motor symptoms
Target: bowel movement every 1–2 days minimum
Maintain high fluid intake — minimum 1.5–2L/day unless contraindicated
Macrogol (Movicol/Laxido) — first choice osmotic laxative
Regular stool softeners (docusate) as standard prescription
Avoid stimulant laxatives as sole treatment — prefer osmotic agents
Document bowel chart daily — escalate if no bowel movement >3 days
Advanced Nutrition Decisions
🔴NG vs PEG in Advanced Disease
Nasogastric (NG) Tube
Short-term option for acute deterioration or NBM; allows medication administration (IR levodopa can be crushed and given via NG); not for long-term use
PEG/PEG-J Tube
For longer-term feeding in severe dysphagia; PEG-J also used for Duodopa intestinal gel delivery; requires multidisciplinary decision including patient/family wishes
Advance Care Planning
The decision to insert a PEG tube in late-stage Parkinson's must involve the patient (if capacity), family, neurologist, SALT, dietitian, and palliative care. Evidence for survival benefit in advanced PD is limited. Document the conversation and the patient's wishes clearly.
Advanced Parkinson's & Device-Aided Therapies
Specialist nursing knowledge for DBS, Duodopa, apomorphine, and end-of-life care
⚡Deep Brain Stimulation (DBS)
What Is DBS?
Implanted electrodes deliver continuous electrical stimulation to deep brain targets (subthalamic nucleus or globus pallidus interna). Connected to an implantable pulse generator (IPG) implanted below the clavicle.
Post-Operative Nursing Care
Wound care: IPG site (chest/clavicle), head incision — monitor for infection, haematoma
IPG site — do not apply pressure; avoid tight bras/clothing over device
Patient provided with programming device — nurse must know how to turn device off in emergency
MRI restrictions — DBS is conditionally MRI safe — requires specific MRI parameters; ALWAYS check with neurosurgery/neurophysiology before any MRI is ordered
Physiotherapy urgently post-DBS — reprogramming may take weeks; patient needs movement support during
Battery life varies (3–5 years rechargeable, or rechargeable systems lasting longer)
Security/airport metal detectors — patient carries an ID card; advise manual screening
🔌Levodopa-Carbidopa Intestinal Gel (Duodopa / LCIG)
Mechanism
Continuous infusion of levodopa-carbidopa gel directly into the jejunum via a PEG-J tube, bypassing gastric emptying variability — provides smooth, continuous levodopa delivery
Nursing Management
PEG-J tube care — clean stoma daily; check for granulation tissue, leakage
Cassette changes — usually daily; requires trained nurse or patient/carer
Store apomorphine in refrigerator; allow to reach room temp before use
Discard if solution is green/discoloured
Palliative Phase
🕊️End-of-Life & Palliative Care in Parkinson's
Advance Care Planning
Begin ACP conversations early — ideally at Hoehn & Yahr III–IV, when patient has capacity. Document DNACPR decisions, preferred place of care, and medication wishes in the patient's notes. Revisit regularly.
Goals of care shift from control to comfort in late disease
Oral medications may become unmanageable — switch to CSCI early
Maintain dignity, comfort, and familiar routines where possible
Involve palliative care team early — not just at terminal stage
Anticipatory / Syringe Driver Medications
SAFE — Midazolam
For agitation, myoclonus, seizures; standard palliative care sedative
SAFE — Levomepromazine
Low-dose antiemetic/sedative; has some D2 blocking but at low palliative doses generally tolerated
SAFE — Morphine / Opioids
For pain, dyspnoea; standard palliative care approach applies
AVOID — Haloperidol
Commonly used in palliative syringe drivers — CONTRAINDICATED in Parkinson's; causes severe extrapyramidal symptoms and distress
GCC-Specific Nursing Considerations
Cultural, environmental, and healthcare context for Parkinson's nursing in the Gulf
🏥Parkinson's Services in the GCC
Movement disorder neurologists present in major tertiary centres across KSA, UAE, Qatar, Kuwait, Bahrain, Oman
Dedicated Parkinson's nurse specialists remain rare — most patients managed by general nurses without Parkinson's-specific training
Saudi Arabia has established movement disorder programmes at KFSH&RC, King Fahd Hospital
Device-aided therapies (DBS, Duodopa) available in major centres
Growing need for Parkinson's nurse specialist training programmes in the GCC
Community support and home nursing for Parkinson's remains underdeveloped compared to UK/Europe
🌡️GCC Hot Climate & Parkinson's
Summer temperatures 40–50°C in GCC create unique risks
Heat + dopaminergic medications = compounded orthostatic hypotension — significantly increased fall risk in summer months
Patients with autonomic dysfunction cannot thermoregulate effectively — risk of heat exhaustion
Counsel patients to avoid outdoor activities in peak heat (10am–4pm summer)
Ensure adequate hydration — dehydration worsens constipation and levodopa absorption
Air-conditioned environments recommended — sudden temperature change can also trigger orthostatic episodes
Check BP lying AND standing routinely in all GCC Parkinson's patients
Cultural Considerations
🤝Barriers to Diagnosis & Treatment
Tremor may be attributed to normal ageing — delayed help-seeking
In some communities, tremor or movement disorder may be attributed to spiritual causes (evil eye, jinn) — patients may seek religious/traditional remedies before medical care
Non-judgemental cultural sensitivity essential — acknowledge beliefs while providing evidence-based information
Stigma around neurological/psychiatric diagnoses — may affect medication adherence and disclosure
Family-centred decision making — involve family appropriately but ensure patient's own wishes are established
Use Arabic-language patient information resources where available
🙏Prayer & Religious Practice
Five daily prayers (Salah) involve specific physical positions — standing, bowing (ruku'), prostration (sujood)
Rigidity, postural instability, and bradykinesia make standard prayer positions difficult or dangerous
Islamic jurisprudence permits seated (chair) or lying prayer when physical ability is impaired — reassure patients that adapted prayer is religiously valid
Timing of levodopa relative to prayer times may be relevant — prayer is at fixed times
Chaplaincy/Islamic scholar input can help patients reconcile religious obligations with physical limitations
Tremor during prayer — acknowledge distress; spiritual support important
Ramadan Fasting & Parkinson's
🌙Fasting in Ramadan — Medication Challenges
Islamic Ruling
Those with chronic illness that worsens with fasting are generally exempted from fasting (fidya — charity-based compensation). However, many patients wish to fast. A personalised plan must be made before Ramadan begins.
Typical Ramadan pattern: eating at Suhoor (pre-dawn) and Iftar (sunset)
Between meals: no food, water, or oral medication during daylight hours
Levodopa must be taken with or around food — long gaps cause severe OFF periods
Medication regimen review 4–6 weeks before Ramadan. Dose consolidation or switch to controlled-release formulations to reduce daily dose frequency.
Suhoor Dose Timing
First levodopa dose with Suhoor meal (pre-dawn). Adjust protein intake at Suhoor to a lighter, lower-protein meal to maximise absorption.
Iftar Dose Timing
Resume doses with Iftar. If multiple doses required, space evening doses carefully — 3–4 doses concentrated between Iftar and Suhoor.
Rotigotine Patch
Can be maintained during fasting hours as it does not constitute oral intake — useful adjunct to reduce pill burden during Ramadan.
Support & Training
📚GCC Parkinson's Support & Nursing Development
Parkinson's support groups in GCC are limited — peer support largely informal or through social media (WhatsApp groups)
Emirates Neurology Society and Saudi Neurosciences Society provide regional education
Parkinson's UK resources widely used in English-speaking GCC nursing community
International Parkinson and Movement Disorder Society (MDS) — training resources available online
Parkinson's nurse specialist pathway — UK model (Queen's Nurse/Parkinson's UK-trained specialist) could be adapted for GCC context
GCC nurses completing ACNS or CNS programmes in neurology can build Parkinson's competencies
Advocate within your institution for Parkinson's-specific nursing education — this guide is a starting point
Arabic Parkinson's resources: Parkinson's disease foundation, WHO neurology resources
Interactive Tool
🕐Parkinson's Medication Timing Planner
Enter the patient's levodopa regimen and meal times to generate an optimised daily medication schedule with protein timing guidance and NBM risk flags.